Related Articles
Neutrophil‑lymphocyte ratio predicts survival in pancreatic neuroendocrine tumors
Surgery management for sporadic small (≤2 cm), non-functioning pancreatic neuroendocrine tumors: a consensus statement by the Chinese Study Group for Neuroendocrine Tumors (CSNET)
Impact of Snail and E-cadherin expression in pancreatic neuroendocrine tumors
Carbohydrate antigen 19‑9 as a prognostic biomarker in pancreatic neuroendocrine tumors
Association of neuroendocrine differentiation with neoadjuvant hormone therapy effects in prostatic cancer